Serum neurofilament light chain in progressive supranuclear palsy
Neurofilament light chain (NfL) is a promising biomarker in neurodegenerative diseases. Elevated NfL levels in CSF and blood have been observed in a growing number of neurodegenerative disorders, including frontotemporal dementia and Alzheimer's disease. We studied serum NfL levels in patients...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Donker Kaat, Laura [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2018 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
4 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Parkinsonism & related disorders - Aral, Efecan ELSEVIER, 2022, official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:56 ; year:2018 ; pages:98-101 ; extent:4 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.parkreldis.2018.06.018 |
|---|
| Katalog-ID: |
ELV045213054 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV045213054 | ||
| 003 | DE-627 | ||
| 005 | 20230624114050.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190205s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.parkreldis.2018.06.018 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000460.pica |
| 035 | |a (DE-627)ELV045213054 | ||
| 035 | |a (ELSEVIER)S1353-8020(18)30277-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 42.13 |2 bkl | ||
| 084 | |a 44.33 |2 bkl | ||
| 100 | 1 | |a Donker Kaat, Laura |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Serum neurofilament light chain in progressive supranuclear palsy |
| 264 | 1 | |c 2018 | |
| 300 | |a 4 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Neurofilament light chain (NfL) is a promising biomarker in neurodegenerative diseases. Elevated NfL levels in CSF and blood have been observed in a growing number of neurodegenerative disorders, including frontotemporal dementia and Alzheimer's disease. We studied serum NfL levels in patients with progressive supranuclear palsy (PSP) in relation to disease severity and survival. | ||
| 650 | 7 | |a Neurofilament |2 Elsevier | |
| 650 | 7 | |a Biomarker |2 Elsevier | |
| 650 | 7 | |a Progressive supranuclear palsy |2 Elsevier | |
| 700 | 1 | |a Meeter, Lieke H. |4 oth | |
| 700 | 1 | |a Chiu, Wan Zheng |4 oth | |
| 700 | 1 | |a Melhem, Shami |4 oth | |
| 700 | 1 | |a Boon, Agnita J.W. |4 oth | |
| 700 | 1 | |a Blennow, Kaj |4 oth | |
| 700 | 1 | |a Zetterberg, Henrik |4 oth | |
| 700 | 1 | |a van Swieten, John C. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Aral, Efecan ELSEVIER |t Parkinsonism & related disorders |d 2022 |d official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders |g Amsterdam [u.a.] |w (DE-627)ELV009218491 |
| 773 | 1 | 8 | |g volume:56 |g year:2018 |g pages:98-101 |g extent:4 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.parkreldis.2018.06.018 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 42.13 |j Molekularbiologie |q VZ |
| 936 | b | k | |a 44.33 |j Physiologische Chemie |q VZ |
| 951 | |a AR | ||
| 952 | |d 56 |j 2018 |h 98-101 |g 4 | ||
| author_variant |
k l d kl kld |
|---|---|
| matchkey_str |
donkerkaatlaurameeterliekehchiuwanzhengm:2018----:eunuoiaetihcannrgesvs |
| hierarchy_sort_str |
2018 |
| bklnumber |
42.13 44.33 |
| publishDate |
2018 |
| allfields |
10.1016/j.parkreldis.2018.06.018 doi GBV00000000000460.pica (DE-627)ELV045213054 (ELSEVIER)S1353-8020(18)30277-3 DE-627 ger DE-627 rakwb eng 610 VZ 42.13 bkl 44.33 bkl Donker Kaat, Laura verfasserin aut Serum neurofilament light chain in progressive supranuclear palsy 2018 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neurofilament light chain (NfL) is a promising biomarker in neurodegenerative diseases. Elevated NfL levels in CSF and blood have been observed in a growing number of neurodegenerative disorders, including frontotemporal dementia and Alzheimer's disease. We studied serum NfL levels in patients with progressive supranuclear palsy (PSP) in relation to disease severity and survival. Neurofilament Elsevier Biomarker Elsevier Progressive supranuclear palsy Elsevier Meeter, Lieke H. oth Chiu, Wan Zheng oth Melhem, Shami oth Boon, Agnita J.W. oth Blennow, Kaj oth Zetterberg, Henrik oth van Swieten, John C. oth Enthalten in Elsevier Science Aral, Efecan ELSEVIER Parkinsonism & related disorders 2022 official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders Amsterdam [u.a.] (DE-627)ELV009218491 volume:56 year:2018 pages:98-101 extent:4 https://doi.org/10.1016/j.parkreldis.2018.06.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 56 2018 98-101 4 |
| spelling |
10.1016/j.parkreldis.2018.06.018 doi GBV00000000000460.pica (DE-627)ELV045213054 (ELSEVIER)S1353-8020(18)30277-3 DE-627 ger DE-627 rakwb eng 610 VZ 42.13 bkl 44.33 bkl Donker Kaat, Laura verfasserin aut Serum neurofilament light chain in progressive supranuclear palsy 2018 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neurofilament light chain (NfL) is a promising biomarker in neurodegenerative diseases. Elevated NfL levels in CSF and blood have been observed in a growing number of neurodegenerative disorders, including frontotemporal dementia and Alzheimer's disease. We studied serum NfL levels in patients with progressive supranuclear palsy (PSP) in relation to disease severity and survival. Neurofilament Elsevier Biomarker Elsevier Progressive supranuclear palsy Elsevier Meeter, Lieke H. oth Chiu, Wan Zheng oth Melhem, Shami oth Boon, Agnita J.W. oth Blennow, Kaj oth Zetterberg, Henrik oth van Swieten, John C. oth Enthalten in Elsevier Science Aral, Efecan ELSEVIER Parkinsonism & related disorders 2022 official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders Amsterdam [u.a.] (DE-627)ELV009218491 volume:56 year:2018 pages:98-101 extent:4 https://doi.org/10.1016/j.parkreldis.2018.06.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 56 2018 98-101 4 |
| allfields_unstemmed |
10.1016/j.parkreldis.2018.06.018 doi GBV00000000000460.pica (DE-627)ELV045213054 (ELSEVIER)S1353-8020(18)30277-3 DE-627 ger DE-627 rakwb eng 610 VZ 42.13 bkl 44.33 bkl Donker Kaat, Laura verfasserin aut Serum neurofilament light chain in progressive supranuclear palsy 2018 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neurofilament light chain (NfL) is a promising biomarker in neurodegenerative diseases. Elevated NfL levels in CSF and blood have been observed in a growing number of neurodegenerative disorders, including frontotemporal dementia and Alzheimer's disease. We studied serum NfL levels in patients with progressive supranuclear palsy (PSP) in relation to disease severity and survival. Neurofilament Elsevier Biomarker Elsevier Progressive supranuclear palsy Elsevier Meeter, Lieke H. oth Chiu, Wan Zheng oth Melhem, Shami oth Boon, Agnita J.W. oth Blennow, Kaj oth Zetterberg, Henrik oth van Swieten, John C. oth Enthalten in Elsevier Science Aral, Efecan ELSEVIER Parkinsonism & related disorders 2022 official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders Amsterdam [u.a.] (DE-627)ELV009218491 volume:56 year:2018 pages:98-101 extent:4 https://doi.org/10.1016/j.parkreldis.2018.06.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 56 2018 98-101 4 |
| allfieldsGer |
10.1016/j.parkreldis.2018.06.018 doi GBV00000000000460.pica (DE-627)ELV045213054 (ELSEVIER)S1353-8020(18)30277-3 DE-627 ger DE-627 rakwb eng 610 VZ 42.13 bkl 44.33 bkl Donker Kaat, Laura verfasserin aut Serum neurofilament light chain in progressive supranuclear palsy 2018 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neurofilament light chain (NfL) is a promising biomarker in neurodegenerative diseases. Elevated NfL levels in CSF and blood have been observed in a growing number of neurodegenerative disorders, including frontotemporal dementia and Alzheimer's disease. We studied serum NfL levels in patients with progressive supranuclear palsy (PSP) in relation to disease severity and survival. Neurofilament Elsevier Biomarker Elsevier Progressive supranuclear palsy Elsevier Meeter, Lieke H. oth Chiu, Wan Zheng oth Melhem, Shami oth Boon, Agnita J.W. oth Blennow, Kaj oth Zetterberg, Henrik oth van Swieten, John C. oth Enthalten in Elsevier Science Aral, Efecan ELSEVIER Parkinsonism & related disorders 2022 official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders Amsterdam [u.a.] (DE-627)ELV009218491 volume:56 year:2018 pages:98-101 extent:4 https://doi.org/10.1016/j.parkreldis.2018.06.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 56 2018 98-101 4 |
| allfieldsSound |
10.1016/j.parkreldis.2018.06.018 doi GBV00000000000460.pica (DE-627)ELV045213054 (ELSEVIER)S1353-8020(18)30277-3 DE-627 ger DE-627 rakwb eng 610 VZ 42.13 bkl 44.33 bkl Donker Kaat, Laura verfasserin aut Serum neurofilament light chain in progressive supranuclear palsy 2018 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neurofilament light chain (NfL) is a promising biomarker in neurodegenerative diseases. Elevated NfL levels in CSF and blood have been observed in a growing number of neurodegenerative disorders, including frontotemporal dementia and Alzheimer's disease. We studied serum NfL levels in patients with progressive supranuclear palsy (PSP) in relation to disease severity and survival. Neurofilament Elsevier Biomarker Elsevier Progressive supranuclear palsy Elsevier Meeter, Lieke H. oth Chiu, Wan Zheng oth Melhem, Shami oth Boon, Agnita J.W. oth Blennow, Kaj oth Zetterberg, Henrik oth van Swieten, John C. oth Enthalten in Elsevier Science Aral, Efecan ELSEVIER Parkinsonism & related disorders 2022 official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders Amsterdam [u.a.] (DE-627)ELV009218491 volume:56 year:2018 pages:98-101 extent:4 https://doi.org/10.1016/j.parkreldis.2018.06.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 56 2018 98-101 4 |
| language |
English |
| source |
Enthalten in Parkinsonism & related disorders Amsterdam [u.a.] volume:56 year:2018 pages:98-101 extent:4 |
| sourceStr |
Enthalten in Parkinsonism & related disorders Amsterdam [u.a.] volume:56 year:2018 pages:98-101 extent:4 |
| format_phy_str_mv |
Article |
| bklname |
Molekularbiologie Physiologische Chemie |
| institution |
findex.gbv.de |
| topic_facet |
Neurofilament Biomarker Progressive supranuclear palsy |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Parkinsonism & related disorders |
| authorswithroles_txt_mv |
Donker Kaat, Laura @@aut@@ Meeter, Lieke H. @@oth@@ Chiu, Wan Zheng @@oth@@ Melhem, Shami @@oth@@ Boon, Agnita J.W. @@oth@@ Blennow, Kaj @@oth@@ Zetterberg, Henrik @@oth@@ van Swieten, John C. @@oth@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
ELV009218491 |
| dewey-sort |
3610 |
| id |
ELV045213054 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV045213054</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624114050.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">190205s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.parkreldis.2018.06.018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000460.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV045213054</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1353-8020(18)30277-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.33</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Donker Kaat, Laura</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Serum neurofilament light chain in progressive supranuclear palsy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Neurofilament light chain (NfL) is a promising biomarker in neurodegenerative diseases. Elevated NfL levels in CSF and blood have been observed in a growing number of neurodegenerative disorders, including frontotemporal dementia and Alzheimer's disease. We studied serum NfL levels in patients with progressive supranuclear palsy (PSP) in relation to disease severity and survival.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neurofilament</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biomarker</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Progressive supranuclear palsy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Meeter, Lieke H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chiu, Wan Zheng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Melhem, Shami</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boon, Agnita J.W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blennow, Kaj</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zetterberg, Henrik</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">van Swieten, John C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Aral, Efecan ELSEVIER</subfield><subfield code="t">Parkinsonism & related disorders</subfield><subfield code="d">2022</subfield><subfield code="d">official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV009218491</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:56</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:98-101</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.parkreldis.2018.06.018</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.13</subfield><subfield code="j">Molekularbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.33</subfield><subfield code="j">Physiologische Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">56</subfield><subfield code="j">2018</subfield><subfield code="h">98-101</subfield><subfield code="g">4</subfield></datafield></record></collection>
|
| author |
Donker Kaat, Laura |
| spellingShingle |
Donker Kaat, Laura ddc 610 bkl 42.13 bkl 44.33 Elsevier Neurofilament Elsevier Biomarker Elsevier Progressive supranuclear palsy Serum neurofilament light chain in progressive supranuclear palsy |
| authorStr |
Donker Kaat, Laura |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV009218491 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 42.13 bkl 44.33 bkl Serum neurofilament light chain in progressive supranuclear palsy Neurofilament Elsevier Biomarker Elsevier Progressive supranuclear palsy Elsevier |
| topic |
ddc 610 bkl 42.13 bkl 44.33 Elsevier Neurofilament Elsevier Biomarker Elsevier Progressive supranuclear palsy |
| topic_unstemmed |
ddc 610 bkl 42.13 bkl 44.33 Elsevier Neurofilament Elsevier Biomarker Elsevier Progressive supranuclear palsy |
| topic_browse |
ddc 610 bkl 42.13 bkl 44.33 Elsevier Neurofilament Elsevier Biomarker Elsevier Progressive supranuclear palsy |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
l h m lh lhm w z c wz wzc s m sm a j b aj ajb k b kb h z hz s j c v sjc sjcv |
| hierarchy_parent_title |
Parkinsonism & related disorders |
| hierarchy_parent_id |
ELV009218491 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Parkinsonism & related disorders |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV009218491 |
| title |
Serum neurofilament light chain in progressive supranuclear palsy |
| ctrlnum |
(DE-627)ELV045213054 (ELSEVIER)S1353-8020(18)30277-3 |
| title_full |
Serum neurofilament light chain in progressive supranuclear palsy |
| author_sort |
Donker Kaat, Laura |
| journal |
Parkinsonism & related disorders |
| journalStr |
Parkinsonism & related disorders |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
zzz |
| container_start_page |
98 |
| author_browse |
Donker Kaat, Laura |
| container_volume |
56 |
| physical |
4 |
| class |
610 VZ 42.13 bkl 44.33 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Donker Kaat, Laura |
| doi_str_mv |
10.1016/j.parkreldis.2018.06.018 |
| dewey-full |
610 |
| title_sort |
serum neurofilament light chain in progressive supranuclear palsy |
| title_auth |
Serum neurofilament light chain in progressive supranuclear palsy |
| abstract |
Neurofilament light chain (NfL) is a promising biomarker in neurodegenerative diseases. Elevated NfL levels in CSF and blood have been observed in a growing number of neurodegenerative disorders, including frontotemporal dementia and Alzheimer's disease. We studied serum NfL levels in patients with progressive supranuclear palsy (PSP) in relation to disease severity and survival. |
| abstractGer |
Neurofilament light chain (NfL) is a promising biomarker in neurodegenerative diseases. Elevated NfL levels in CSF and blood have been observed in a growing number of neurodegenerative disorders, including frontotemporal dementia and Alzheimer's disease. We studied serum NfL levels in patients with progressive supranuclear palsy (PSP) in relation to disease severity and survival. |
| abstract_unstemmed |
Neurofilament light chain (NfL) is a promising biomarker in neurodegenerative diseases. Elevated NfL levels in CSF and blood have been observed in a growing number of neurodegenerative disorders, including frontotemporal dementia and Alzheimer's disease. We studied serum NfL levels in patients with progressive supranuclear palsy (PSP) in relation to disease severity and survival. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Serum neurofilament light chain in progressive supranuclear palsy |
| url |
https://doi.org/10.1016/j.parkreldis.2018.06.018 |
| remote_bool |
true |
| author2 |
Meeter, Lieke H. Chiu, Wan Zheng Melhem, Shami Boon, Agnita J.W. Blennow, Kaj Zetterberg, Henrik van Swieten, John C. |
| author2Str |
Meeter, Lieke H. Chiu, Wan Zheng Melhem, Shami Boon, Agnita J.W. Blennow, Kaj Zetterberg, Henrik van Swieten, John C. |
| ppnlink |
ELV009218491 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.parkreldis.2018.06.018 |
| up_date |
2024-07-06T16:54:49.196Z |
| _version_ |
1803849447977779200 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV045213054</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624114050.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">190205s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.parkreldis.2018.06.018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000460.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV045213054</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1353-8020(18)30277-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.33</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Donker Kaat, Laura</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Serum neurofilament light chain in progressive supranuclear palsy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Neurofilament light chain (NfL) is a promising biomarker in neurodegenerative diseases. Elevated NfL levels in CSF and blood have been observed in a growing number of neurodegenerative disorders, including frontotemporal dementia and Alzheimer's disease. We studied serum NfL levels in patients with progressive supranuclear palsy (PSP) in relation to disease severity and survival.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neurofilament</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biomarker</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Progressive supranuclear palsy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Meeter, Lieke H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chiu, Wan Zheng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Melhem, Shami</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boon, Agnita J.W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blennow, Kaj</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zetterberg, Henrik</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">van Swieten, John C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Aral, Efecan ELSEVIER</subfield><subfield code="t">Parkinsonism & related disorders</subfield><subfield code="d">2022</subfield><subfield code="d">official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV009218491</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:56</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:98-101</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.parkreldis.2018.06.018</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.13</subfield><subfield code="j">Molekularbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.33</subfield><subfield code="j">Physiologische Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">56</subfield><subfield code="j">2018</subfield><subfield code="h">98-101</subfield><subfield code="g">4</subfield></datafield></record></collection>
|
| score |
7.4004526 |